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Available online - - -AbstractBackground: Enhanced Recovery After Surgery (ERAS) has been proven effective in liver surgery. Adherence to the ERAS pathway is
variable. This study seeks to evaluate adherence to key components of an ERAS protocol in liver resection, and identify the components
associated with successful clinical outcomes.
Method: All patients undergoing liver resections for two consecutive years were included in our ERAS pathway. Six key components of
ERAS included preoperative assessment, nutrition and gastrointestinal function, postoperative analgesia, mobilisation and discharges. Suc-
cessful accomplishment of ERAS was defined as hospital discharge by postop day (POD) 6. Adherences of these elements were compared
between the successful and un-successful groups.
Results: During the studied period, 223 patients underwent liver resections, among which 103 had major hepatectomies. N ¼ 147 patients
(66%) were discharged within our ERAS protocol target (6 days). On multivariable analysis, sitting out of bed by POD 1 (p < 0.03),
walking by POD 3 (p ¼ 0.03), removal of urinary catheter by POD 3 (p < 0.01), and avoiding major complications (p < 0.01) were factors
associated with successful completion to our ERAS protocol; whereas advanced age (p ¼ 0.34) and discontinuation of PCA/epidural by
POD 3 (p ¼ 0.50) were not significant parameters. There was a significant difference in the length of stay (p < 0.01) following major
and minor liver resection, of which the indications for surgery also varied significantly. There was no difference in hospital re-
admission rate, and morbidity and mortality between major and minor liver resection.
Conclusions: Facilitating early mobilisation and reducing postoperative complications are keys to successful outcomes of ERAS in liver
resection.
Crown Copyright  2016 Published by Elsevier Ltd. All rights reserved.
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Enhanced Recovery After Surgery (ERAS) is a ‘fast-
track’ recovery process that has been proven effective in
liver surgery as well as a variety of clinical settings
including colorectal, urological and vascular surgery.1e5 It
has been shown to be effective in reducing complications,
hospital stay, and delivery cost efficiency for surgical
care.5 It focuses in utilising a multimodal recovery strategythor. Fax: þ44 7092 088 991.
incent.yip@nhs.net (V.S. Yip).
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/dx.doi.org/10.1016/j.ejso.2016.07.015to minimise trauma of surgery, and accelerate postoperative
recovery.6
Uptake of ERAS in liver surgery was slower to other
surgical specialties owing to concerns adopting its methods.
A systematic review in 2012 identified only six studies on
ERAS during hepatobiliary surgery,7 and all of these
studies were limited in terms of patient numbers.8 More
recently, larger series have been published on ERAS
following hepatectomy.2,9e11 However, despite reporting
on ‘consecutive hepatectomies’, with the exception of
Dunne et al., all these series had exclusion criteria,
including biliary reconstruction, hilar cholangiocarcinoma,
and advanced age.9e11 The majority of these studies aimedved.
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Table 1
Summary of ERAS pathway for liver resection.
Time point Goals
Referral  Discussion of referral and review of all imag-
ing in MDT
First clinic
appointment
 Patient education initiated, discussion of the
full care pathway with internet video
illustration
 Discussion of intended operative intervention,
and the associated risks and complications
Preoperative
assessment
 Cardio-pulmonary exercise testing
 Assessment in preoperative clinic
 Review by dedicated liver anaesthetist, and
discuss postop analgesia option
Day of admission  Review of operative intervention, risks and
2 V.S. Yip et al. / EJSO xx (2016) 1e7to evaluate whether ERAS was feasible following liver sur-
gery. A limited number of studies reported the outcomes of
a true consecutive cohort of patients undergoing hepatec-
tomy within an ERAS program.11,12
Having all these multimodal approaches combined into
a single clinical pathway, it is difficult to fully ascertain
which key components within the pathway dictate
outcome. This study seeks to evaluate adherence to key
components of an ERAS protocol in liver resection, and
identify the components associated with successful clin-
ical outcomes.
Materials and methodsexpected outcomes.
 Review of expectations of enhanced recoveryStudy cohort
Day of surgery  Minimise use of drains
 No nasogastric tube use
 Selective critical care admission post surgery
 Commence oral fluid
 Sit out of bed postop, if possible
Postop day 1  Sat out of bed at least 8 h
 4 walks of 30 m or more
 Respiratory physiotherapy review
 Review by acute pain team
 Commence full diet as tolerated
 Discharge planning meeting
Postop day 2  Maintain oral intake
 If epidural in use place Fentanyl patch
(25 mcg/h) at 22:00
 If PCA aim to convert to oral analgesia
 Sat out of bed at least 8 h
 4 walks of 40 m or more
Postop day 3  Removal of epidural analgesia
 Discontinue supplemental oxygen if satura-
tions within normal range.
 Maintain oral intake
 Sat out of bed at least 8 hWe fully implemented our ERAS pathway for all pa-
tients undergoing hepatectomies in May 2010.2 Our
ERAS pathway has previously been described but is sum-
marised in Table 1.2
All patients undergoing elective hepatectomy, including
both laparoscopic and open surgeries, between May 2010
and June 2012 were included in our study. All data were
prospectively collected. Data collected included adherence
to six key elements of the ERAS protocol. These are preop-
erative assessment, operative factors, postoperative mobili-
sation, nutrition, postoperative analgesia and discharges.
Operative factors include major/minor resections, type of
operations and postoperative complications, which were
classified according to the DindoeClavien classification.13
Major complication was defined as having complications of
Grade IIIb or above. Major hepatectomy is defined as liver
resection for 3 or more consecutive segments.14 4 walks of 60 m or more
 Plan dischargePreoperative assessment and risk stratificationPostop day 4e6  Maintain oral intake
 Sat out of bed at least 8 h
 4 walks of 60 m or more
Discharge if:
 Tolerating full oral intake
 Pain adequately controlled
 Passing flatus and urine normally
 Normal routine observations
 Independently mobile and deemed safe for
discharge
 Patient and family happy for discharge
Day 1 post discharge  Phone review with cancer specialist nurse
(CNS)Our integrated ERAS pathway commences at the
hepatobiliary specialist multi-disciplinary team (sMDT)
meeting, where patients are identified for surgical interven-
tions. Postoperative social circumstances for each patient
were addressed by our clinical specialist nurses prior to surgery.
Following formal preoperative assessment, an individu-
alised perioperative care plan was developed in conjunction
with the sMDT decision. This was further stratified based
on a combination of anaesthetic review, and the results of
Cardio-Pulmonary Exercise Test (CPET), if performed. Pa-
tients were classified as low, intermediate, or high-risk by a
dedicated liver anaesthetist. This was in part subjective, but
all patients with a relative oxygen uptake of <11 ml/kg/min
on preoperative CPET were automatically classified as
high-risk.15 All high-risk patients were electively admitted
to the critical care unit following surgery, whereas patients
categorised as low risk were admitted to standard ERAS
ward care. Intermediate risk patients could be admitted to
the standard ERAS ward at the discretion of the specialist
liver anaesthesiologist.Please cite this article in press as: Yip VS, et al., Adherence to early mobilisatio
Oncol (2016), http://dx.doi.org/10.1016/j.ejso.2016.07.015Anaesthetic managementPatients were allowed to eat and drink until 6 h preop-
eratively, with clear fluids only 2 h before surgery. All pa-
tients undergoing hepatectomy had a thoracic epidural for
postoperative analgesia, unless contraindicated or pa-
tient’s choice (see below). Two large bore cannulas, inter-
nal jugular central venous lines, and urinary catheter were
used prior to intervention. Cardiac output monitoring wasn: Key for successful enhanced recovery after liver resection, Eur J Surg
3V.S. Yip et al. / EJSO xx (2016) 1e7used to guide fluid management and optimize organ
perfusion. The pulse contour continuous cardiac output
(PiCCO) was used for high-risk resections, and a bolus
indicator cardiac monitor (LiDCO) for lower risk
resections.
Low CVP level was achieved with a combination
of thoracic epidural, fluid restriction pre- and intra-
operatively, and nitrate infusion if required. All patients
had prophylactic antibiotics at induction of anaesthesia us-
ing cefuroxime and metronidazole. Hypothermia was pre-
vented by routine intra-operative monitoring and the use
of an air-warming system. Calf compression stockings
and devices were used intra-operatively for venous
thrombotic prophylaxis. Glycaemic control was monitored
throughout the operation.Surgical procedureA reverse L-shaped or right subcostal incision was uti-
lised for the hepatectomy. Intra-operative ultrasound imag-
ing was conducted to assess the suitability of the planned
resection. Liver parenchyma was transected using either
the Kelly-clasia technique or Cavitron Ultrasonic Surgical
Aspirator, with or without intermittent inflow occlusion.
Drains were not routinely used.Postoperative analgesiaEpidural analgesia delivered using Levobupivacaine
0.1% and Fentanyl 2 mcg ml via a thoracic epidural was
the standard method of postoperative pain management, un-
less patient preference using patient-controlled analgesia
(PCA) following preoperative anaesthetic assessment. The
epidural was discontinued at 8 am on the third postopera-
tive day, with a single Fentanyl patch applied to ease the
transition to oral analgesia. The specialist pain management
team supported all pain management.Perioperative care planPatients were admitted on the day of operation, unless
precluded by clinical or social circumstances. Pathway
components are illustrated in Table 1. Patients were
considered eligible for discharge once they were toler-
ating full oral intake, adequate pain-control, passing
flatus and urine, normal clinical and acceptable biochem-
ical parameters. Patients had to be deemed independently
mobile and safe for discharge by the ward staff and phys-
iotherapist. Nurse-led discharge was incorporated within
the protocol to allow an efficient and safe discharge at
all times.Accomplishment and adherence of ERAS protocolOur ERAS pathway aims for completion (and discharge)
by day 6. Non-adherence is defined by length of stayPlease cite this article in press as: Yip VS, et al., Adherence to early mobilisatio
Oncol (2016), http://dx.doi.org/10.1016/j.ejso.2016.07.015beyond the ERAS pathway. Adherence to the following
specific ERAS elements were assessed: sitting out of bed
by POD 1; oral diet by POD 1; walking by POD 2; removal
of thoracic epidural by POD 3; removal of urinary catheter
by POD 3; passing flatus by POD 5. These were selected as
they were felt to represent major clinical milestones in the
postoperative recovery by the clinical team.
Our primary outcome was to evaluate how adherence to
these six specific ERAS elements affected the successful
completion of our ERAS pathway by day 6. Secondary out-
comes compared postoperative complications and hospital
re-admission after discharge between the adherent and
non-adherent groups.Statistical analysisCategorical data were presented as frequency and pro-
portions (%) and analysed using the Pearson’s chi-
squared test or Fisher’s exact test. Median and range were
used to describe continuous data, which were compared
by using the ManneWhitney test.
Univariate analysis was performed to assess ERAS ele-
ments between the adherent and non-adherent groups. A
multivariable analysis was performed to evaluate variables,
which were found to be significant on univariate analysis.
All statistical analyses were performed using the SigmaPlot
v.12 for Windows (Systat, US), and statistical significance
was taken at the 5% level.
ResultsStudy populationDuring the studied period, 223 patients underwent hepa-
tectomy within the ERAS program, of which 167 resections
were for colorectal liver metastases, 15 for benign liver dis-
ease, 27 for hilar/intra-hepatic cholangiocarcinoma, and 17
for hepatocellular carcinoma (HCC). Among the 167 pa-
tients for colorectal liver metastases, 3 had laparoscopic liver
resections. Median age was 67 years (range: 28e87). Of
these 223 patients, 103 (46.2%) had a major hepatectomy,
and 150 (67.3%) of them were male (see Table 2).Adherence of specific elements to ERAS protocolOne hundred and forty-seven patients (65.9%) were dis-
charged by day 6, and classified as successfully completing
the ERAS. Median length of stay (LoS) for the whole
cohort was 6 days (range: 1e71).
By POD 1, 160 (72%) patients had commenced full oral
diet, and 173 (77.6%) had managed to sit out of bed.
N ¼ 177 patients (79.3%) started walking with the assis-
tance of physiotherapist by day 2. The majority of patients
(n ¼ 147, 65.9%) opted for thoracic epidural as the sole
analgesic control, whereas 13.9% (n ¼ 31) had PCA alone,
and 20.2% (n ¼ 45) required both epidural and PCA ton: Key for successful enhanced recovery after liver resection, Eur J Surg
Table 2
Demographic, key components and major complications (ClavieneDindo classification: Grade IIIb or above) for ERAS compliant (LoS  6) and non-
compliant groups (LoS > 6).
Length of stay > 6 days (n ¼ 76) Length of stay  6 days (n ¼ 147) p-value
Demographics
Male gender 49 (64.5%) 98 (66.7%) 0.858
Age  80 8 13 0.868
Preoperative assessment
Anticipated risk (low:medium:high) 10:43:6 38:77:5 0.051
HDU admission postop 57 (75%) 88 (59.8%) 0.036*
Anticipated early admission prior surgery 28 (36.8%) 37 (25.2%) 0.096
Nutrition and gastrointestinal function
Commencement of oral diet > POD 1 27 (40.3%) 36 (26.3%) 0.061
Failure to passed flatus by POD 5 1 0 0.689
Type of resections
Major hepatectomy 46 (60.5%) 55 (37.4%) 0.002*
Postoperative analgesia
Epidural:PCA:combined epidural and PCA 51:5:19 96:26:24 0.040*
Epidural removal > POD 3 12 (19.4%) 11 (9.7%) 0.112
PCA removal > POD 3 6 (46.2%) 4 (11.1%) 0.014*
Combined analgesia > POD 3 17 (25.4%) 14 (10.4%) 0.011*
Mobilisation
Sat out of bed > POD 1 28 (41.2%) 22 (15.7%) <0.001*
Walking > POD 2 27 (40.9%) 19 (13.9%) <0.001*
Catheter removal > POD 3 28 (45.2%) 11 (8.6%) <0.001*
Hospital re-admission rate after discharge 7 (9.2%) 5 (3.4%) 0.131
Reasons for hospital re-admission
Symptomatic control (e.g. nausea and vomiting,
including pain relief)
2 2
Complications (including collection) 4 2
Others 1 1
Unscheduled critical care admission 7 (9.2%) 1 (0.7%) 0.004
Major complications (Grade IIIb or above) 16 (21.0%) 2 (13.6%) <0.001*
Grade IIIb 13 (17.1%) 1 (13.3%)
Re-intervention (7) Bile leak with intervention (1)
Bile leak with intervention (5)
Grade IVa 2 (2.5%)
Pneumonia: re-intubation (2)
Grade IVb/V 3 (1.3%)
Multi-organ dysfunction (3)
*Indicates statistically significant findings with p < 0.05.
Italic and bold italic values indicates statistically significant findings with p < 0.05.
4 V.S. Yip et al. / EJSO xx (2016) 1e7achieve effective pain management. Over 86% (n ¼ 192) of
patients were successfully discontinued from either PCA or
epidural or the combination of both by POD 3. Urinary
catheters were removed from more than 82% (n ¼ 184)
of patients by POD 3. Only l patient had not established
normal gut function by POD 5.Univariate and multivariable analysis of ERAS
factors for prolonged LoSOn univariate analysis specific ERAS factors associated
with a LoS > 6 days included not sitting out of bed by POD
1 (p < 0.001), failure to establish walking at 2 days postop-
eratively (p < 0.001), failure to discontinue epidural anal-
gesia or PCA by POD 3 (p ¼ 0.011), and not having the
urinary catheter removed by day 3 (p < 0.001).
Other factors associated with LoS > 6 days included un-
dergoing major hepatectomy (p ¼ 0.002), age 80Please cite this article in press as: Yip VS, et al., Adherence to early mobilisatio
Oncol (2016), http://dx.doi.org/10.1016/j.ejso.2016.07.015(p ¼ 0.029), elective postoperative HDU admission
(p ¼ 0.036), and the development of Grade III and IV com-
plications (<0.001).
On multivariable analysis, sitting out by POD 1
(p ¼ 0.029), walking by POD 3 (p ¼ 0.033), removal of uri-
nary catheter by POD 3 (p ¼ 0.002), and avoiding major
complications (p < 0.001) were independent factors associ-
ated with successful compliance to our ERAS protocol;
whereas elderly age (p ¼ 0.341), and earlier discontinua-
tion of PCA/epidural by day 3 (p ¼ 0.549) were not signif-
icant parameters (see Table 3).Adherence to ERAS in major and minor liver
resectionsAlthough major hepatectomy was associated with a
slightly younger age group (major: minor, 63.5 vs. 69,
p < 0.03) as compared to minor resections, more patientsn: Key for successful enhanced recovery after liver resection, Eur J Surg
Table 3
Multi-variate analysis of variables influencing length of stay > 6 days.
Clinical variables
for LoS > 6
Multi-variate
analysis
Risk
ratio
Confidence
interval
Age 0.341 1.016 0.983e1.049
Sat out of bed by POD 1 0.029* 2.739 1.110e6.757
Walking by POD 2 0.033* 2.776 1.086e7.095
Removal of urinary catheter
by POD 3
0.002* 4.702 1.737e12.732
Cessation of PCA and epidural
by POD 3
0.495 1.482 0.478e4.594
Major complications
(ClavieneDindo > Grade III)
<0.001* 23.439 4.453e123.367
*Indicates statistically significant findings with p < 0.05.
Bold italic values indicates statistically significant findings with p < 0.05.
5V.S. Yip et al. / EJSO xx (2016) 1e7with major resections had limited overall mobility and a
longer period with catheter in situ after surgery (Table 4).
However, the extent of liver resection was not associated
with increased incidence of major complication
(p ¼ 0.515). Major liver resection is therefore likely to
be a confounding factor for poor mobilisation and delayed
urinary catheter removal.Morbidity and mortalityThe overall morbidity in our cohort (ClavieneDindo
1e5) was 35.0% (n ¼ 78/223), with major complications
(ClavieneDindo  IIIb) occurring in 19 (8.5%) patients.
The overall 90-day mortality was 1.3% (n ¼ 3/223). Two
of the patients who died (re-laparotomy for small bowel
ischaemia and postoperative myocardial infarction) hadTable 4
Demographic and key components for minor and major hepatectomies.
Type of resections Minor resect
Demographics
Male gender 82 (66.7%)
Median age, range 69 (28e85)
Tumour aetiology
CRLM 105 (87.8%)
Hepatocellular carcinoma 10 (8.1%)
Cholangiocarcinoma 2 (1.6%)
Benign 6 (4.9%)
Median length of stay 5
Preoperative assessment
Planned HDU postop 62 (50.4%)
Nutrition and gastrointestinal function
Commencement of oral diet > POD 1 28 (24.8%)
Failure to pass flatus by POD 5 0
Postoperative analgesia
Analgesia > POD 3 (including both PCA & epidural) 13 (11.9%)
Mobilisation
Sit out of bed > POD 1 15 (12.9%)
Walk > POD 2 12 (10.8%)
Catheter removal > POD 3 14 (13.9%)
Major complications 9 (7.3%)
*Indicates statistically significant findings with p < 0.05.
Bold italic values indicates statistically significant findings with p < 0.05.
Please cite this article in press as: Yip VS, et al., Adherence to early mobilisatio
Oncol (2016), http://dx.doi.org/10.1016/j.ejso.2016.07.015major resections for colorectal liver metastases and the
third following resection of a hilar cholangiocarcinoma
(acute fulminant liver and multiple organ failures).Critical care admission and hospital re-admission
ratesOverall postoperative HDU admission and hospital re-
admission after discharge rates were 65.0% (n ¼ 145)
and 5.4% (n ¼ 12/220, with the exclusion of the 3 deaths),
respectively. There was no difference in hospital re-
admission rate between the successful and non-successful
groups (p ¼ 0.131).Discussion
Achieving early mobilisation and early removal of uri-
nary catheters were key to a successful ERAS pathway
and early discharge following liver surgery. This is depen-
dent on the avoidance of postoperative complications, as
would be expected logically. However, age does not pre-
clude patients from the enrolment to ERAS following
hepatectomy.
Early mobilisations by sitting the patient out of bed by
POD 1, and walking by POD 2 were associated with a suc-
cessful adherence to ERAS criteria. In colorectal surgery,
mobilisation by POD 3 was highlighted as an independent
factor associated with a successful outcome of ERAS for
laparoscopic colorectal surgery.16,17 Smart et al. further
demonstrated that failure to mobilise was associated with
an early deviation from the ERAS protocol in colorectalions (n ¼ 123) Major resections (n ¼ 103) p-value
68 (66%) 0.858
63.5 (28e87) 0.029*
65 (63.1%) <0.001*
15 (14.6%)
15 (14.6%)
8 (7.8%)
6 <0.001*
86 (83.5%) <0.001*
35 (37.2%) 0.074
1 0.929
19 (20.4%) 0.145
35 (37.2%) <0.001*
34 (36.6%) <0.001*
25 (27.8%) 0.028*
11 (10.7%) 0.515
n: Key for successful enhanced recovery after liver resection, Eur J Surg
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hepatectomy.
One of the most recent studies of ERAS looking at re-
covery after major liver surgery focused on the accomplish-
ment of the ERAS criteria, rather than the total length of
hospital stay.18 Although there is growing awareness that
LoS is not equivalent to a good final outcome measure,
and that postoperative patient-reported outcome/quality of
life survey might be better outcome measurements,19 it is
nevertheless a key criteria for measuring a successful
ERAS programme. The majority of delayed discharges
were due to social and domestic factors.18 In this cohort,
nearly a quarter of patients would have achieved the
ERAS criteria, which were set out as Takamoto et al.18 in
their protocol, but were not discharged by POD 6. It is
therefore our opinion that achieving ERAS criteria alone
is not an adequate reflection of accomplishing successful
ERAS. Our philosophy for an effective ERAS programme
is that ERAS should commence at the point of the decision
for surgery, at which time any potential delays after surgery
are identified, and ideally rectified, prior to surgical
intervention.
Delay to removal of a urinary catheter is also associated
with deviation from our ERAS protocol. Similar finding
was also identified in ERAS studies after colorectal sur-
gery.17 This delay could possibly be explained by the auto-
nomic blockade following thoracic epidural, or other
significant confounding variables such as poor mobility
and the development of complications. In our ERAS pro-
tocol, the urinary catheter would not be removed as long
as the thoracic epidural is in-situ for the concerns of devel-
oping urinary retention. However, one randomised
controlled trial (RCT) demonstrated that early urinary
catheter removal on POD 1 having had epidural analgesia
led to a lower urinary tract infection rate, and did not in-
crease re-catheterisation rate.20 It might therefore be worth
evaluating whether early removal of urinary catheter on
POD 1 can further enhance the recovery process following
liver surgery.
Advanced age and prolonged use of either epidural or
PCAwere associated with extended LoS in univariate anal-
ysis, but not on multivariable analysis. This finding implies
that elderly age and prolonged use of epidural or PCA are
confounders for other factors, such as poor mobility, but are
not the key parameters for the failure of ERAS in liver sur-
gery. Our finding is in conflict with those of Takamoto
et al., who concluded that age was associated with pro-
longed LoS.18 This may be due to their focus on major hep-
atectomy, suggesting that age is more relevant in more
extensive surgery.
Major resections were associated with slower mobili-
sation and delay in urinary catheter removal. However,
we had proportionally more patients with intrahepatic/hi-
lar cholangiocarcinoma or hepatocellular carcinoma
(HCC) underwent major hepatectomies in our cohort as
compared to other studies.9,21e23 This is likely becausePlease cite this article in press as: Yip VS, et al., Adherence to early mobilisatio
Oncol (2016), http://dx.doi.org/10.1016/j.ejso.2016.07.015of our non-exclusion criteria to enrol any liver resection
patients into our ERAS protocol. Despite having the
same anatomical extent of resection for patients with
HCC, cholangiocarcinoma and liver metastases, the
patho-physiological effects vary widely among these
three groups of patients. There were more underlying
liver parenchymal dysfunctions in HCC and cholangio-
carcinoma than liver metastases, where these patients
will have better preserved liver functions prior to inter-
vention.21,24 This preoperative parenchymal dysfunction
would potentially affect the rate of recovery, and hence
ERAS outcomes.
Overall morbidity in our series was 35.0%, with major
complications (Grade III or above) in 8.5%; whereas our
overall mortality was 1.3%. These findings are again not
dissimilar to the experience of other centres utilising
ERAS in liver surgery.21,22,24e28 This finding is lower
than those treated ‘traditionally’ in other centres.29e31
Despite the difference in recovery rate demonstrated in
our cohort between major and minor hepatectomy, there
were no differences in their associated morbidities. Our
re-admission rate for this study is 5.4%, which is similar
to other ERAS series.21,23,27 When compared ERAS to con-
ventional care, other studies again did not demonstrate any
significant difference in their hospital re-admission rate.
These findings further confirmed that ERAS is safe
following liver resections.
Whilst this study is limited by its retrospective design,
this series offers a true reflection of ERAS in clinical prac-
tice, without any exclusion, as opposed to its use in clinical
trials or highly selected groups of patients.9,24 The other
limitation in this series is its lack of case-matching for
either major or minor hepatectomy according to the under-
lying tumour aetiologies. This can potentially introduce
bias in our data analysis.
In conclusion, ERAS should be considered as a standard
of care for all patients undergoing liver resection. Old age
should not be used as a de-selection criterion for enrolling
patients for ERAS following hepatectomies. It is important
to focus on early mobilisation and early removal of the uri-
nary catheter, which are essential to ensure a successful
ERAS program for liver resections.Conflict of interest
None declared.Source of funding
Self-funded.Ethical approval
Ethical approval is not required for this study.n: Key for successful enhanced recovery after liver resection, Eur J Surg
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